FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

FierceBiotech names Confo Therapeutics as…

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

Ghent, Belgium, and Dresden, Germany…

Confo Therapeutics receives €1.7 million grant from VLAIO

Ghent, Belgium, 20 June 2019…

Confo Therapeutics raises €30 million in Series A financing

Round led by BioGeneration Ventures…